Recent

% | $
Quotes you view appear here for quick access.

Pacific Biosciences of California, Inc. Message Board

  • spOOkchaser spOOkchaser Sep 21, 2011 1:22 PM Flag

    I'm hoping --

    that this company is NOT just another big science project that went public to make the owners rich.
    I was cautious about buying until they actually shipped some units (15 or 16 ?) and had revs of more then double of estimates for last qtr.
    I felt I was just lucky to have waited until the price was cut in 1/2 to ~$6 before I bought.
    Now they claim that sales are not there and thats why the layoffs are happening.

    It is nearly impossible for a person who is not strong in the life-sciences to grasp the nuances of the biotech industry---and that includes me. This is why I never went after a biotech drug co. One bad word from the FDA and BAM! you lose 50%

    I felt that a sequencing company ( THE RIGHT ONE) would be selling hardware to MANY of the biotechs and was a safer bet. But picking the winner is a tough chore.
    I do see that ILMN took a big hit today also, so just maybe the BIG players are rotating out of the group for a while----or just picking up cheap shares as it slides.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I own GNOM. Not sure if you follow the company or not? I feel their total outsourced sequencing model allows for a more economical choice amongst research and clinical institutions.

      Rather than investing large sums of $$ upfront in sequencing equipment, personel, office space, etc, GNOM provides everything needed to analyze the gene (via the cloud) at a fraction of the cost.

      That said, it seems this space has experienced a slowdown in demand due to the overall economy and constrained research budgets. It's hard to argue with this technology being a game changer in the world of medicine, but unless folks are willign to adopt it, hard to say just when it will take off??

      • 1 Reply to spittinimage6
      • GNOM---That is an interesting business model they have ---sequencing as a service. BUT--at some point in their process, a sequencing machine has to be used. In their case it appears to be some sort of array on a chip.
        I simply cannot say if this approach is technically superior to PACB or any other approach.
        The question remains--what sequencing machine company or companies will be the ultimate winner?

        Sequencing machines are not a commodity item, so there is still major money to be made in building the hardware, and suppling the consumables (Razors & Blades analogy) Maybe the gimmick is to basically FLOOD the market with your machines and make the $$$$ with your consumables.

        My take is that there is room for a few GOOD companies to win---with some of them perhaps specializing in a specific aspect of the sequencing market.

    • Hey i don't know I agree this is a hard to pick sector but I got in with a 1k shares at $4.52 and it seem to have bottom so let's hope it head up tomorrow.

 
PACB
5.69+0.15(+2.71%)Jul 31 4:00 PMEDT